BRWD3 rabbit pAb
ENT-A5414
Description
| REF | ENT-A5414 |
|---|---|
| Category | Antibody Polyclonal |
| Description | BRWD3 rabbit pAb |
| Source | Rabbit |
| Applications | WB;IHC;IF;ELISA |
| Reactivity | Human;Mouse |
| Reactivity | Human;Mouse |
| Dilution | Western Blot: 1/500 – 1/2000. Immunohistochemistry: 1/100 – 1/300. ELISA: 1/40000. Not yet tested in other applications. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human BRWD3. AA range:1751-1800 |
| Storage Stability | -20°C/1 year |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1 mg/ml |
| Observed Band KD | 204kD |
| Human Gene ID | 254065 |
| Human Swiss Prot Nº | Q6RI45 |
| Subcellular Location | nucleus, |
Other Name: BRWD3; Bromodomain and WD repeat-containing protein 3
Background: The protein encoded by this gene contains a bromodomain and several WD repeats. It is thought to have a chromatin-modifying function, and may thus play a role in transcription. Mutations in this gene cause mental retardation X-linked type 93, which is also referred to as mental retardation X-linked with macrocephaly. This gene is also associated with translocations in patients with B-cell chronic lymphocytic leukemia. [provided by RefSeq, May 2010],